While infectious diseases remain a significant health problem, it has been estimated that non-communicable diseases will become the leading cause of death in Ghana by 2025. Despite the steadily rising incidence of cancer across sub-Saharan Africa, few medical facilities have any capacity to provide effective diagnosis and care for even the most common malignancies.

The HopeXchange Medical Center seeks to become the premiere hub for cancer care and research in West Africa, with state of the art diagnostic and treatment capabilities offered to all in need. Clinical Programs focus on community-based screening for common cancers, including breast, cervical, prostate and colorectal malignancies. Diagnostic services (radiology and clinical pathology) are provided at HopeXchange to those identified through outreach screening efforts, as well as healthcare providers and facilities throughout Ghana. Treatment regimens are being developed to ensure safe and effective monitoring of both effectiveness and toxicity. Research Programs seek to define cancer incidence within the Ashanti region, as well as establish appropriate screening methods for those cancers for which early detection leads to improved outcomes.